-
Options Brief: Myriad Genetics
Friday, July 29, 2011 - 12:20pm | 73Shares of Myriad Genetics (NASDAQ: MYGN) are lower on the session by 0.54%, trading at $21.21. Overall call volume is now running at 5.11x the daily average, with 36% of all calls traded being purchases on the offer. 1,420 contracts have traded on the session so far. Myriad Genetics, Inc. is a...
-
Calls Purchased on Savient Pharmaceuticals
Friday, July 29, 2011 - 11:55am | 124Shares of Savient Pharmaceuticals (NASDAQ: SVNT) are higher on the session by 0.43%, currently trading at $7.02. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are buying calls on the name today. A short...
-
Rodman & Renshaw Reiterates Curis Market Outperform, $6 PT
Friday, July 29, 2011 - 11:33am | 100Rodman & Renshaw reiterated its Curis (NASDAQ: CRIS) Market Outperform / Speculative Risk rating and $6 price target in a research report published today. In the report, Rodman & Renshaw states, "With the CUDC-101 program advancing in the clinic, GDC-0449 being evaluated in inoperable BCC...
-
Options Brief: Cephalon
Friday, July 29, 2011 - 10:02am | 77Shares of Cephalon (NASDAQ: CEPH) are lower on the session by 0.05%, trading at $80.05. Overall call volume is now running at 2.07x the daily average, with 0% of all calls traded being purchases on the offer. 1,676 contracts have traded on the session so far. Cephalon, Inc. is a global...
-
US Stock Futures Down On Debt Worries
Friday, July 29, 2011 - 6:13am | 527US stock futures are lower this morning, after Thursday's House budget vote on the US debt ceiling was rescheduled. Futures for the Dow Jones Industrial Average dipped 55 points to 12,138.00 and S&P 500 index futures fell 5.70 points to 1,291.10. Nasdaq 100 futures dropped 7.75 points to 2,362....
-
Earnings Scheduled For July 29
Friday, July 29, 2011 - 4:18am | 424Chevron Corporation (NYSE: CVX) is projected to report its Q2 EPS at $3.56 on revenue of $71.58 billion. Aon Corporation (NYSE: AON) is expected to report its Q2 EPS at $0.82 on revenue of $2.74 billion. Newell Rubbermaid Inc (NYSE: NWL) is estimated to report its Q2 EPS at $0.42 on revenue of $...
-
Stocks To Watch For July 29
Friday, July 29, 2011 - 3:39am | 259Some of the stocks that may grab investor focus today are: Wall Street expects Merck & Company Inc (NYSE: MRK) to report its Q2 EPS at $0.95 on revenue of $11.78 billion. Merck shares dropped 0.74% to close at $34.93 yesterday. Starbucks Corp (NASDAQ: SBUX) reported its Q2 profit at $279...
-
Few Trade Ideas for Friday, July 29
Thursday, July 28, 2011 - 5:54pm | 1452( click to enlarge ) Pharmacyclics, Inc. (NASDAQ:PCYC) is firming just above its 20-day moving average over the last few days. This is a neutral pattern dependent on a break to establish a directional bias. A break below $11.80 would signal a decline and be quite bearish, on the other hand...
-
Pfizer Earnings Preview: Analysts Expect Falling EPS
Thursday, July 28, 2011 - 3:40pm | 569Pfizer (NYSE: PFE) announces its next round of earnings this Tuesday, August 2, 2011. Here is Benzinga's everything-that-matters guide for this Tuesday's second quarter earnings announcement. Earnings and Revenue: Based on estimates, investors are readying for a positive EPS reading of 59...
-
Icagen Stockholders Contest Proposed Acquisition Price of $6/share by Pfizer in Letter to Board
Thursday, July 28, 2011 - 2:08pm | 107Merlin Nexus and New Leaf Venture Partners, stockholders in Icagen, Inc. (Nasdaq: ICGN), disclosed today a letter submitted to the Icagen Board contesting the Company's planned acquisition by Pfizer Inc (NYSE: PFE). According to a July 20, 2011 press announcement, Pfizer plans to purchase the 8.3...
-
C.K. Cooper Reiterates QLT Buy, $12 PT
Thursday, July 28, 2011 - 1:09pm | 74C.K. Cooper reiterated its QLT (NASDAQ: QLTI) Buy rating and $12 price target in a research report published today. In the report, C.K. Cooper states, "We believe that the company's assets coupled with the near and medium-term developmental pipeline (retinoid & punctual plugs) represent...
-
NASDAQ Winners July 27th: Marshall Edwards, Novogen, Acxiom, IAC
Thursday, July 28, 2011 - 11:28am | 506POINT ROBERTS, July 28, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 27, 2011. Thursday, Oncology Company, Marshall Edwards, Inc topped the market winners with a gain of over 135%. Marshall...
-
Biotech and Pharma News; BioSante Pharmaceuticals Prices Public Offering of Common Stock
Thursday, July 28, 2011 - 10:47am | 994LINCOLNSHIRE, Ill. - July 28, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the pricing of its previously announced underwritten public offering of 16.0 million shares of its common stock, offered at a price of $3.00 per share to the public. The...
-
Options Brief: Dynavax Technologies
Thursday, July 28, 2011 - 10:10am | 75Shares of Dynavax Technologies (NASDAQ: DVAX) are higher on the session by 24.28%, trading at $3.02. Overall call volume is now running at 23.31x the daily average, with 19% of all calls traded being purchases on the offer. 2,508 contracts have traded on the session so far. Dynavax Technologies...
-
Options Brief: Onyx Pharmaceuticals
Thursday, July 28, 2011 - 10:09am | 85Shares of Onyx Pharmaceuticals (NASDAQ: ONXX) are higher on the session by 2.86%, trading at $33.42. Overall call volume is now running at 2.13x the daily average, with 7% of all calls traded being purchases on the offer. 1,787 contracts have traded on the session so far. Onyx Pharmaceuticals,...